• Users Online: 249
  • Print this page
  • Email this page
Year : 2022  |  Volume : 2  |  Issue : 1  |  Page : 6-10

Stereotactic Arrhythmia Radioablation (STAR)

Department of Radiation Oncology, AIG Hospitals, Hyderabad, India

Correspondence Address:
Nanditha Sesikeran Boindala
Department of Radiation Oncology, AIG Hospitals, Gachibowli, Hyderabad- 500032
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/bjoc.bjoc_12_22

Rights and Permissions

Ventricular tachycardia(VT) is a wide complex tachyarrhythmia which could be potentially life-threatening. Standard treatment options include catheter ablation, anti-arrhythmic drugs and ICDs (Implantable cardioverter defibrillator). In patients refractory to the above treatments, limited options are available. Stereotactic arrhythmia radio-ablation (STAR) is a novel non-invasive method of ablating the arrhythmogenic substrate using high dose of highly focused radiotherapy. This technique requires a multi-disciplinary team consisting of Cardiologist, Electrophysiologist, Radiation oncologist and Radiologist to integrate pre-treatment imaging and electro-physiological data to generate a target that can be radiated. Studies show excellent control of VT, 6–12 weeks post-treatment with no major toxicities. This article attempts to provide a practical step by step approach to stereotactic arrhythmia radioablation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded67    
    Comments [Add]    

Recommend this journal